Bullish Stocks With Record All-Time High: $MUSA $MOR $PAG

The Market Signal was created as a platform to help investors, if you own (NYSE:MUSA), (NASDAQ:MOR) or (NYSE:PAG) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.

https://themarketsignal.com/ Free-Report/NOW

(Click link above or copy, paste and hit enter in your browser for your report)

Murphy USA is bullish on new of record funds raised to support Boys & Girls Clubs of America youth

https://themarketsignal.com/Free-Report/MUSA

(Click link above or copy, paste and hit enter in your browser for your report)

Murphy USA Inc. (NYSE:MUSA) is trading at $136.71 near its all time high of $144.09

Murphy USA Inc. (NYSE: MUSA) has announced that its employees and customers have raised over $1 million that will towards supporting Boys & Girls Clubs of America youth. The achievement comes after the company and the youth advocacy organisations entered a partnership.

The company launched the campaign in April around 1,500 of its stores in 25 states. During the campaign, customers were asked to either round-up their purchases to the dollar amount or make a monetary contribution of $1, $2 or $5.

MorphoSys is trending after issuing important updates for Q2 2020

https://themarketsignal.com/Free-Report/MOR

(Click link above or copy, paste and hit enter in your browser for your report)

MorphoSys AG (NASDAQ:MOR) is trading at $30.55 near its all time high of $37.96

MorphoSys AG has issued important updates for the second quarter of 2020. During the quarter, the FDA approved the company's Monjuvi(R) (tafasitamab-cxix) which is used in combination with lenalidomide to treat adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

The company also secured validation of European Marketing Authorization Application (MAA) for tafasitamab in combination with lenalidomide. In addition, MorphoSys qwas granted validation for its tafasitamab monotherapy used in the treatment of r/r DLBCL in adults. MorphoSys also made follow-ups on previously announced results from the on-going L-MIND study in r/r DLBCL.

Penske Automotive Group is bullish with improved liquidity

https://themarketsignal.com/Free-Report/PAG

(Click link above or copy, paste and hit enter in your browser for your report)

Penske Automotive Group, Inc. (NYSE:PAG) is trading at $49.60 near its all time high of $56.05

Penske Automotive Group, Inc has announced repayment in full its $300 million Senior Subordinated Notes following maturity on August 15, 2020. The company repaid the Notes from its revolving credit facility. The repayment has raised the company's liquidity to over $800 million under the revolving credit facility.

In addition, Penske Automotive has also announced completing the issuance of $500 million aggregate principal amount of 3.5% of the Senior Subordinated Notes. The Notes ate due in 2025 and the company intends to use the proceeds to redeem its $550 million of the 5.75% of Senior Subordinated Notes.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

comtex tracking

COMTEX_371058014/2705/2020-09-10T06:42:04

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.